TCI Wealth Advisors’s Kronos Bio KRON Stock Holding History

TCI Wealth Advisors’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-145	Closed	-$3K	–	2424
2021 Q3	$3K	Buy	145 +47	+48%	+$1.01K	﹤0.01%	1954
2021 Q2	$2K	Buy	+98	New	+$2.48K	﹤0.01%	2034

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Wealth Advisors's KRON Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Kronos Bio (KRON) in Q4 2021, closing a stake of 145 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in KRON in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 81 funds tracked by Wall St. Rank hold KRON as of Q4 2021.

TCI Wealth Advisors reported no remaining Kronos Bio position as of Q4 2021 after selling out during the quarter.
TCI Wealth Advisors sold 145 Kronos Bio shares in Q4 2021, an estimated $3K.
TCI Wealth Advisors first reported a position in Kronos Bio in Q2 2021 and held it in 2 quarters.
TCI Wealth Advisors's Kronos Bio position peaked at $3K in Q3 2021.
81 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.